Latest Japan News

Memphasys has rapidly established a foothold in the UK IVF market, securing four active commercial trials and initial orders for its Felix™ sperm selection system within weeks of launch. This momentum aligns with its global expansion strategy targeting major fertility markets.

International Graphite Limited has inked a non-binding deal with Wogen Pacific to supply micronised graphite and feedstock for its Collie facility, targeting Asia-Pacific markets with an initial three-year term.

Bankers Investment Trust reported a 3.7% NAV total return for the half-year to April 2026, outpacing the FTSE World Index, while declaring a 3.1% dividend increase. Fund manager Alex Crooke announced retirement, with Richard Clode set to take the helm.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.

TALi Digital is transforming its established educational programs into an AI-driven platform, leveraging a validated cognitive technology and a national footprint in over 500 schools to tap a largely under-penetrated market.

Memphasys has secured $1.2 million through a share placement to support the global expansion and manufacturing scale-up of its Felix™ sperm selection system. The company also extended a major convertible note, reinforcing financial flexibility amid growing international contracts.

Memphasys has locked in a 12-month exclusive supply agreement with Monash IVF for its Felix™ sperm selection system, marking its biggest commercial contract to date and setting a foundation for recurring revenue.

icetana AI has expanded its strategic partnership with SoftBank Robotics Group by signing a distribution agreement with SoftBank Robotics America, marking its entry into one of the world's largest security technology markets.

Control Bionics advances its neural-signal technology across assistive communication, sports, and medical sectors, securing key US reimbursement and distribution agreements while broadening its international footprint.

Opthea Limited resumes ASX trading as it pivots to develop OPT-302 for lymphangioleiomyomatosis, outlining a disciplined 18-month staged clinical program backed by A$31.2 million in cash.

Ardea Resources delays the final report for its Kalgoorlie Nickel Project’s Goongarrie Hub DFS beyond June 2026 while initiating a new scandium scoping study, maintaining strong government backing and consortium funding.